首页> 美国卫生研究院文献>Therapeutics and Clinical Risk Management >Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors tocilizumab or abatacept in osteoporosis with rheumatoid arthritis

【2h】

Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors tocilizumab or abatacept in osteoporosis with rheumatoid arthritis

机译：在抗类风湿关节炎骨质疏松症中地诺单抗对抗TNF抑制剂tocilizumab或abatacept的骨代谢和骨矿物质密度的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

IntroductionThe aim of this 18-month retrospective study was to evaluate the differences in outcomes of denosumab with tumor necrosis factor (TNF) inhibitors (TNFis), tocilizumab (TCZ), or abatacept (ABT) treatment in osteoporosis (OP) patients with rheumatoid arthritis (RA).

机译：简介这项为期18个月的回顾性研究旨在评估denosumab与肿瘤坏死因子（TNF）抑制剂（TNFis），托珠单抗（TCZ）或abatacept（ABT）治疗在类风湿性关节炎骨质疏松症（OP）患者中的差异（RA）。

著录项

期刊名称 Therapeutics and Clinical Risk Management
作者
Takako Suzuki; Yukio Nakamura; Hiroyuki Kato;
展开▼
作者单位

展开▼
年(卷),期 2018(14),-1
年度 2018
页码 453–459
总页数 7
原文格式 PDF
正文语种
中图分类病理学;
关键词
abatacept denosumab rheumatoid arthritis TNF inhibitors tocilizumab;

机译：阿巴西普;地诺单抗;类风湿关节炎;TNF抑制剂;托珠单抗;

相似文献

外文文献
中文文献
专利

1. Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis [J] . Takako Suzuki, Yukio Nakamura, Hiroyuki Kato Therapeutics and Clinical Risk Management . 2018,第5期

机译：在抗类风湿关节炎的骨质疏松症中，地诺单抗对抗TNF抑制剂，托珠单抗或阿巴西普对骨代谢和骨矿物质密度的影响
2. Effects of romosozumab or denosumab treatment on the bone mineral density and disease activity for 6 months in patients with rheumatoid arthritis with severe osteoporosis: An open-label, randomized, pilot study [J] . Takeshi Mochizuki, Koichiro Yano, Katsunori Ikari, Osteoporosis and Sarcopenia . 2021,第3期

机译：romoSozumab或Denosumab治疗对具有严重骨质疏松症的类风湿性关节炎患者骨矿物密度和疾病活性的影响：开放标签，随机，试点研究
3. 24-MONTH TREATMENT WITH DENOSUMAB IN PATIENTS WITH OSTEOPOROSIS AND RHEUMATOID ARTHRITIS: EFFECTS ON BONE MINERAL DENSITYAND STRUCTURAL DAMAGE [J] . Kovalenko P., Dydykina I., Smirnov A., Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . 2016,第Suppla1期

机译：骨质疏松症和类风湿关节炎患者使用去甲舒巴妥钠治疗24个月：对骨密度和结构损伤的影响
4. Automated segmentation of knee and ankle regions of rats from CT images to quantify bone mineral density for monitoring treatments of rheumatoid arthritis [C] . Francisco Cruz, Raquel Sevilla, Joe Zhu, Conference on biomedical applications in molecular, structural, and functional imaging . 2014

机译：从CT图像自动分割大鼠的膝盖和脚踝区域，以量化骨矿物质密度，以监测类风湿性关节炎的治疗
5. Osteoporosis: Identification of factors associated with fracture, bone mineral density, bone geometry and bone strength in older adults [D] . Barbour, Kamil. 2010

机译：骨质疏松症：确定与老年人骨折，骨矿物质密度，骨几何形状和骨强度有关的因素
6. Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates [O] . Tetsuya Kaneko, Koichi Okamura, Yukio Yonemoto, 2019

机译：地诺单抗对双膦酸盐类风湿关节炎患者骨矿物质密度和骨转换指标的影响
7. Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis [O] . Takako Suzuki, Yukio Nakamura, Hiroyuki Kato 2018

机译：deaosumab对骨质抑制剂骨代谢和骨矿物质密度的影响，与类风湿性关节炎骨质疏松症骨质疏松症或骨折

Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors tocilizumab or abatacept in osteoporosis with rheumatoid arthritis

摘要

著录项

相似文献

相关主题

期刊订阅